Topic
Semiconductor Research
Research across global markets indicates a robust environment for technology-related sectors, driven largely by Nasdaq outperformance and the ongoing integration of AI. The transition of biotechnology toward a scalable industry relies heavily on AI-driven drug discovery, a trend that underscores the increasing importance of high-performance computing infrastructure. Tactical regional themes, particularly in Asian technology, are highlighted as key opportunities for satellite portfolios seeking growth. Furthermore, the global tech economy’s strength is reflected in institutional hedging shifts and record equity highs, despite market caution regarding the exact pace of AI monetization. Recent technical moves, including a 25-year record outperformance in software relative to the S&P 500, suggest a period of high factor volatility and concentrated demand in tech-adjacent growth sectors. As markets navigate these geopolitical and technical shifts, analysts recommend enhancing portfolio resilience through exposure to resilient global markets like Japan and diversifying into alternative assets.
4216 reports available
All reports
Page 162 of 176
Market FAQ Ahead of Trump-Xi Meeting
Goldman Sachs · May 12, 2026
Multi Asset Strategy Daily
Mizuho International · May 12, 2026
Early Morning Reid
Deutsche Bank · May 11, 2026
CSL First Take FY26 Trading Downgrade
Goldman Sachs · May 11, 2026
Shift Up Corp 1Q26 Review
Goldman Sachs · May 11, 2026
Capacity Expansion Plans and Direct Customer Investment
Goldman Sachs · May 11, 2026
Elia Group Structurally Compelling
Goldman Sachs · May 11, 2026
Softbank Corp Upside Potential and New Medium Term Plan
Goldman Sachs · May 11, 2026
China Healthcare Services Drug Chains FY25 and 1Q26 Wrap Up
Goldman Sachs · May 11, 2026
China Hospital Equipment Bidding Update April 2026
Goldman Sachs · May 11, 2026
Updating Estimates Post Q1 2026
Goldman Sachs · May 11, 2026
The Options Market Has Flipped
Goldman Sachs & Co. LLC · May 11, 2026
Cheniere Energy 1Q26 Recap
Goldman Sachs · May 11, 2026
Fox Corp F3Q26 Review EBITDA Beat
Goldman Sachs · May 11, 2026
Europe Capital Goods 1Q26 Heatmap and CNH Update
Goldman Sachs · May 11, 2026
Fidelity National Information Services 1Q26 Takeaways
Goldman Sachs · May 11, 2026
BioAge Labs R&D Day and NLRP3 Asset Analysis
Goldman Sachs · May 11, 2026
FinecoBank SpA: Management Meeting Takeaways
Goldman Sachs · May 11, 2026
Seronegative Approval Reinforces Vyvgart's MG Positioning
Goldman Sachs · May 11, 2026
1Q26 Takeaways: Slight Core Beat with Stronger Top Line Across the Board
Goldman Sachs · May 11, 2026
China AIDC and Power Corporate Day Takeaways
Goldman Sachs · May 11, 2026
BinDawood Holding 1Q26 Earnings First Take
Goldman Sachs · May 11, 2026
Cenomi Centers 1Q26 Earnings Call Takeaways
Goldman Sachs · May 11, 2026
Key Takeaways From 1Q26 Conference Call - Caixa Seguridade
Goldman Sachs · May 11, 2026